Bench-to-bedside review: bacterial pneumonia with influenza - pathogenesis and clinical implications.
Seasonal and pandemic influenza are frequently complicated by bacterial infections, causing additional hospitalization and mortality. Secondary bacterial respiratory infection can be subdivided into combined viral/bacterial pneumonia and post-influenza pneumonia, which differ in their pathogenesis. During combined viral/bacterial infection, the virus, the bacterium and the host interact with each other. Post-influenza pneumonia may, at least in part, be due to resolution of inflammation caused by the primary viral infection. These mechanisms restore tissue homeostasis but greatly impair the host response against unrelated bacterial pathogens. In this review we summarize the underlying mechanisms leading to combined viral/bacterial infection or post-influenza pneumonia and highlight important considerations for effective treatment of bacterial pneumonia during and shortly after influenza.
van der Sluijs
Koenraad F
KF
Departments of Pulmonology and Experimental Immunology, Academic Medical Center, Amsterdam, The Netherlands. kvandersluijs@amc.uva.nl
van der Poll
Tom
T
Lutter
René
R
Juffermans
Nicole P
NP
Schultz
Marcus J
MJ
D015897:Comorbidity; D006801:Humans; D007251:Influenza, Human / Q000188:drug therapy / Q000503:physiopathology* / Q000821:virology; D018410:Pneumonia, Bacterial / Q000188:drug therapy / Q000453:epidemiology / Q000503:physiopathology*
Int J Chron Obstruct Pulmon Dis. 2007;2(1):55-64
18044066
J Immunol. 2004 Jun 15;172(12):7603-9
15187140
JAMA. 2009 Nov 4;302(17):1872-9
19822627
Lancet Infect Dis. 2005 Nov;5(11):718-25
16253889
Science. 1964 May 15;144(3620):862-3
14151624
J Immunol. 2000 Oct 1;165(7):3934-40
11034401
J Allergy Clin Immunol. 2006 Dec;118(6):1199-206; quiz 1207-8
17157648
Nature. 2009 Jun 25;459(7250):1122-5
19516283
Adv Exp Med Biol. 1982;141:647-54
7090935
Infection. 2009 Jun;37(3):186-96
19471854
Schweiz Med Wochenschr. 1985 Jan 19;115(3):75-86
3883482
J Exp Med. 2004 Jul 19;200(2):267-72
15263032
Am J Respir Cell Mol Biol. 2010 Apr;42(4):450-60
19520922
Cell Death Differ. 2002 Oct;9(10):1069-77
12232795
Chest. 2001 Jun;119(6):1717-23
11399696
N Engl J Med. 2009 Jun 18;360(25):2605-15
19423869
Eur J Clin Microbiol. 1982 Jun;1(3):171-7
7173182
Am J Physiol Lung Cell Mol Physiol. 2006 Jan;290(1):L194-9
16100290
Antimicrob Agents Chemother. 2003 Jan;47(1):48-53
12499168
Clin Infect Dis. 2007 Mar 1;44 Suppl 2:S27-72
17278083
Am Rev Respir Dis. 1986 Nov;134(5):1040-4
3777666
Vaccine. 2002 Aug 19;20(25-26):3068-87
12163258
Am J Respir Cell Mol Biol. 2007 May;36(5):609-14
17170383
Nature. 1993 Jun 3;363(6428):418-23
8502295
J Infect Dis. 2003 Oct 15;188(8):1119-31
14551881
N Engl J Med. 2004 Dec 16;351(25):2611-8
15602021
Virus Genes. 1995;11(2-3):209-15
8828147
Nat Med. 2009 Mar;15(3):277-84
19234462
Blood. 1999 Apr 1;93(7):2395-403
10090951
J Virol. 2000 Apr;74(7):3399-403
10708457
Nat Med. 2004 Aug;10(8):811-3
15247911
BMC Infect Dis. 2006 Mar 20;6:58
16549029
Vaccine. 2008 Sep 12;26 Suppl 4:D45-8
19230159
J Immunol. 1989 Jun 15;142(12):4401-6
2723434
Crit Care Med. 2005 May;33(5):952-61
15891319
Comp Med. 2007 Feb;57(1):82-9
17348295
J Exp Med. 2008 Feb 18;205(2):323-9
18227219
Biochem Soc Trans. 2009 Aug;37(Pt 4):811-3
19614599
Antivir Ther. 2007;12(4 Pt B):593-602
17944267
Blood. 1994 Apr 1;83(7):1929-34
7511443
J Immunol. 2004 Sep 15;173(6):3748-54
15356121
J Virol. 1984 May;50(2):287-92
6708169
JAMA. 2009 Nov 4;302(17):1896-902
19887665
J Infect Dis. 2004 Feb 15;189(4):711-6
14767826
J Clin Invest. 2009 Jul;119(7):1910-20
19487810
Cell Microbiol. 2008 Jan;10(1):237-46
17711480
Infect Immun. 2000 Apr;68(4):2286-93
10722631
J Am Chem Soc. 1997 Jan 29;119(4):681-90
16526129
Circ Res. 2006 Nov 24;99(11):1261-9
17068293
South Med J. 2003 Aug;96(8):740-3
14515911
Nature. 1995 Oct 5;377(6548):435-8
7566121
Infect Immun. 2006 Dec;74(12):6707-21
16982840
J Infect Dis. 2009 Feb 1;199(3):311-9
19113989
Infect Immun. 2000 Jan;68(1):133-40
10603379
J Gen Virol. 1987 Jul;68 ( Pt 7):2039-41
3298542
J Infect Dis. 2006 Jan 15;193(2):214-22
16362885
Eur Respir J. 2006 Apr;27(4):795-800
16585087
Scand J Immunol. 1977;6(9):897-906
905779
Cell Host Microbe. 2007 Oct 11;2(4):240-9
18005742
J Gen Virol. 2003 Sep;84(Pt 9):2389-2400
12917460
Int J Cardiol. 2008 Nov 28;130(3):304-9
18625525
J Infect Dis. 2004 Aug 1;190(3):519-26
15243927
Int J Pediatr Otorhinolaryngol. 1992 Jan;23(1):15-23
1592548
J Infect Dis. 2009 Aug 15;200(4):537-45
19586418
J Infect Dis. 2003 Mar 15;187(6):1000-9
12660947
J Leukoc Biol. 2001 Jan;69(1):50-6
11200067
Infect Immun. 1983 Aug;41(2):618-23
6347892
Lancet. 1958 Nov 29;2(7057):1141-3
13612141
Scand J Infect Dis. 2008;40(1):11-7
17852951
J Virol Methods. 2001 May;94(1-2):173-86
11337052
Am J Med. 2008 Apr;121(4):258-64
18374680
MMWR Morb Mortal Wkly Rep. 2009 Oct 2;58(38):1071-4
19798021
Nat Med. 2008 May;14(5):558-64
18438414
Med J Aust. 2006 Nov 20;185(S10):S44-7
17115951
Semin Respir Infect. 2002 Mar;17(1):47-56
11891518
J Infect Dis. 2005 Jul 15;192(2):249-57
15962219
Ann Clin Biochem. 2001 May;38(Pt 3):242-51
11392499
Br J Dis Chest. 1980 Jan;74(1):56-62
7356914
Infect Immun. 1982 Jan;35(1):350-5
7054126
J Infect Dis. 2008 Oct 1;198(7):962-70
18710327
Bioinformatics. 2009 Sep 15;25(18):2309-17
19706746
Am J Med. 2005 Mar;118(3):285-91
15745727
Crit Care Med. 2010 Apr;38(4 Suppl):e91-7
19935413
J Infect Dis. 2002 Aug 1;186(3):341-50
12134230